For: | Duseja A, Das R, Nanda M, Das A, Garewal G, Chawla Y. Nonalcoholic steatohepatitis in Asian Indians is neither associated with iron overload nor with HFE gene mutations. World J Gastroenterol 2005; 11(3): 393-395 [PMID: 15637751 DOI: 10.3748/wjg.v11.i3.393] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v11/i3/393.htm |
Number | Citing Articles |
1 |
Jian-Gao Fan, Seung-Up Kim, Vincent Wai-Sun Wong. New trends on obesity and NAFLD in Asia. Journal of Hepatology 2017; 67(4): 862 doi: 10.1016/j.jhep.2017.06.003
|
2 |
Mohd Talha Noor, Manish Tiwari, Ravindra Kumar. Non-HFE iron overload as a surrogate marker of disease severity in patients of liver cirrhosis. Indian Journal of Gastroenterology 2016; 35(1): 33 doi: 10.1007/s12664-016-0623-6
|
3 |
M. Srinivas, Vijaya Srinivasan, Madhu Bashini Mohan, Joy Varghese, Jayanthi Venkataraman. A study of gender-wise risk association between fatty liver and metabolic syndrome components (Asia-Pacific criteria) in a South Indian urban cohort. Indian Journal of Gastroenterology 2015; 34(1): 38 doi: 10.1007/s12664-014-0525-4
|
4 |
Abhishek Goyal, Bishav Mohan, Kavita Saggar, Gurpreet Singh Wander. Primary haemochromatosis resulting in dilated cardiomyopathy arising out of mutation in HJV gene in Indian patients: a rare scenario. BMJ Case Reports 2020; 13(9): e235650 doi: 10.1136/bcr-2020-235650
|
5 |
Ajay Duseja, Naga Chalasani. Epidemiology and risk factors of nonalcoholic fatty liver disease (NAFLD). Hepatology International 2013; 7(S2): 755 doi: 10.1007/s12072-013-9480-x
|
6 |
P. Nahon, N. Ganne-Carrié, J.-C. Trinchet, M. Beaugrand. Hepatic iron overload and risk of hepatocellular carcinoma in cirrhosis. Gastroentérologie Clinique et Biologique 2010; 34(1): 1 doi: 10.1016/j.gcb.2009.07.032
|
7 |
Shivakumar Chitturi, Geoffrey C Farrell, Etsuko Hashimoto, Toshiji Saibara, George KK Lau, José D Sollano. Non‐alcoholic fatty liver disease in the Asia–Pacific region: Definitions and overview of proposed guidelines. Journal of Gastroenterology and Hepatology 2007; 22(6): 778 doi: 10.1111/j.1440-1746.2007.05001.x
|
8 |
Ajay Duseja. Nonalcoholic fatty liver disease in India – a lot done, yet more required!. Indian Journal of Gastroenterology 2010; 29(6): 217 doi: 10.1007/s12664-010-0069-1
|
9 |
Yoshio Sumida, Toshikazu Yoshikawa, Takeshi Okanoue. Role of hepatic iron in non‐alcoholic steatohepatitis. Hepatology Research 2009; 39(3): 213 doi: 10.1111/j.1872-034X.2008.00442.x
|
10 |
Antonello Pietrangelo, Michael Torbenson. Macsween's Pathology of the Liver. 2018; : 275 doi: 10.1016/B978-0-7020-6697-9.00004-2
|
11 |
Naoki Fujita, Yoshiyuki Takei. . Advances in Clinical Chemistry 2011; 55: 105 doi: 10.1016/B978-0-12-387042-1.00006-X
|
12 |
Halis Simsek, Yasemin H. Balaban, Hale Sümer, Engin Yılmaz, Gonca Tatar. HFE Mutations Analysis of Turkish Patients with Nonalcoholic Steatohepatitis. Digestive Diseases and Sciences 2006; 51(10): 1723 doi: 10.1007/s10620-006-9114-4
|
13 |
MARIANA MACHADO, HELENA CORTEZ‐PINTO. Nash, insulin resistance and iron. Liver International 2006; 26(10): 1159 doi: 10.1111/j.1478-3231.2006.01394.x
|
14 |
Maha Guindi. Practical Hepatic Pathology: A Diagnostic Approach. 2011; : 177 doi: 10.1016/B978-0-443-06803-4.00014-9
|
15 |
Hye Young Kim, Woo Young Kwon, Joon Beom Park, Mi Hwa Lee, Yoo Jin Oh, SungHwan Suh, Yang Hyun Baek, Jin Sook Jeong, Young Hyun Yoo. Hepatic STAMP2 mediates recombinant FGF21‐induced improvement of hepatic iron overload in nonalcoholic fatty liver disease. The FASEB Journal 2020; 34(9): 12354 doi: 10.1096/fj.202000790R
|
16 |
Zoon Tariq, Charlotte J. Green, Leanne Hodson. Are oxidative stress mechanisms the common denominator in the progression from hepatic steatosis towards non‐alcoholic steatohepatitis (NASH)?. Liver International 2014; 34(7) doi: 10.1111/liv.12523
|
17 |
Masato Yoneda, Yuichi Nozaki, Hiroki Endo, Hironori Mawatari, Hiroshi Iida, Koji Fujita, Kyoko Yoneda, Hirokazu Takahashi, Hiroyuki Kirikoshi, Masahiko Inamori, Noritoshi Kobayashi, Kensuke Kubota, Satoru Saito, Shiro Maeyama, Kikuko Hotta, Atsushi Nakajima. Serum Ferritin Is a Clinical Biomarker in Japanese Patients with Nonalcoholic Steatohepatitis (NASH) Independent of HFE Gene Mutation. Digestive Diseases and Sciences 2010; 55(3): 808 doi: 10.1007/s10620-009-0771-y
|
18 |
Reena Das, Giriraj Ratan Chandak. Obscure pathogenesis of primary iron overload in Indians warrants more focused research. Indian Journal of Gastroenterology 2011; 30(4): 154 doi: 10.1007/s12664-011-0119-3
|
19 |
James E. Nelson, Heather Klintworth, Kris V. Kowdley. Iron Metabolism in Nonalcoholic Fatty Liver Disease. Current Gastroenterology Reports 2012; 14(1): 8 doi: 10.1007/s11894-011-0234-4
|
20 |
Richard Kirsch, Helene P. Sijtsema, Mpho Tlali, Adrian D. Marais, Pauline de la M Hall. Effects of iron overload in a rat nutritional model of non‐alcoholic fatty liver disease. Liver International 2006; 26(10): 1258 doi: 10.1111/j.1478-3231.2006.01329.x
|
21 |
Ajay Duseja, Ashim Das, Reena Das, R. K. Dhiman, Y. Chawla, A. Bhansali, Naveen Kalra. The Clinicopathological Profile of Indian Patients with Nonalcoholic Fatty Liver Disease (NAFLD) is Different from That in the West. Digestive Diseases and Sciences 2007; 52(9): 2368 doi: 10.1007/s10620-006-9136-y
|
22 |
Carolin Lackner. Practical Hepatic Pathology: a Diagnostic Approach. 2018; : 167 doi: 10.1016/B978-0-323-42873-6.00012-3
|
23 |
Eleftheria Makri, Myrsini Orfanidou, Evangelia S. Makri, Antonis Goulas, Evangelos Terpos, Stergios A. Polyzos. Circulating Ferritin in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis. Journal of Clinical and Experimental Hepatology 2024; 14(3): 101353 doi: 10.1016/j.jceh.2024.101353
|
24 |
Alan C. Paterson, Antonello Pietrangelo. MacSween's Pathology of the Liver. 2012; : 261 doi: 10.1016/B978-0-7020-3398-8.00005-2
|
25 |
Mariana Verdelho Machado, Anna Mae Diehl. Zakim and Boyer's Hepatology. 2018; : 369 doi: 10.1016/B978-0-323-37591-7.00025-2
|
26 |
Swastik Agrawal, Ajay K Duseja. Non-alcoholic Fatty Liver Disease: East Versus West. Journal of Clinical and Experimental Hepatology 2012; 2(2): 122 doi: 10.1016/S0973-6883(12)60101-7
|
27 |
Kotacherry T. Shenoy, Leena K. Balakumaran, Philip Mathew, Mohan Prasad, Boddu Prabhakar, Ajit Sood, Shivaram P. Singh, Nagaraj P. Rao, Shoukat A. Zargar, Angelo A. Bignamini. Metadoxine Versus Placebo for the Treatment of Non-alcoholic Steatohepatitis: A Randomized Controlled Trial. Journal of Clinical and Experimental Hepatology 2014; 4(2): 94 doi: 10.1016/j.jceh.2014.03.041
|
28 |
Maha Guindi. Practical Hepatic Pathology: a Diagnostic Approach. 2018; : 151 doi: 10.1016/B978-0-323-42873-6.00011-1
|
29 |
V. C. S. Srinivasarao Bandaru, Jaydip R. Chaudhury, Palle Lalitha, Somala N. Reddy, Pradeep K. Misra, Banda Balaraju, Kandadai R. Mridula. Prevalence of asymptomatic nonalcoholic fatty liver disease in nondiabetic participants: a study from south india. The Egyptian Journal of Internal Medicine 2019; 31(1): 92 doi: 10.4103/ejim.ejim_76_18
|
30 |
Hye Young Kim, Young Hyun Yoo. The Role of STAMP2 in Pathogenesis of Chronic Diseases Focusing on Nonalcoholic Fatty Liver Disease: A Review. Biomedicines 2022; 10(9): 2082 doi: 10.3390/biomedicines10092082
|
31 |
Richard Kirsch, Ralph Kirsch. Nutrition, Diet Therapy, and the Liver. 2009; : 97 doi: 10.1201/9781420085501.ch7
|
32 |
Amanda J. Hooper, Leon A. Adams, John R. Burnett. Genetic determinants of hepatic steatosis in man. Journal of Lipid Research 2011; 52(4): 593 doi: 10.1194/jlr.R008896
|
33 |
Raseen Tariq, Page Axley, Ashwani K. Singal. Extra-Hepatic Manifestations of Nonalcoholic Fatty Liver Disease: A Review. Journal of Clinical and Experimental Hepatology 2020; 10(1): 81 doi: 10.1016/j.jceh.2019.07.008
|
34 |
Vlad Pădureanu, Dalia Dop, Alice Drăgoescu, Rodica Pădureanu, Anca Mușetescu, Laurențiu Nedelcu. Non‑alcoholic fatty liver disease and hematologic manifestations (Review). Experimental and Therapeutic Medicine 2021; 22(6) doi: 10.3892/etm.2021.10790
|
35 |
James E. Nelson, Renuka Bhattacharya, Keith D. Lindor, Naga Chalasani, Stuart Raaka, Jenny E. Heathcote, Emil Miskovsky, Eldon Shaffer, Stephen J. Rulyak, Kris V. Kowdley. HFE C282Y mutations are associated with advanced hepatic fibrosis in Caucasians with nonalcoholic steatohepatitis. Hepatology 2007; 46(3): 723 doi: 10.1002/hep.21742
|
36 |
Darrell H. G. Crawford, Linda M. Fletcher, Kris V. Kowdley. Iron Physiology and Pathophysiology in Humans. 2012; : 441 doi: 10.1007/978-1-60327-485-2_22
|
37 |
Ajay Duseja, Yogesh Kumar Chawla. Obesity and NAFLD. Clinics in Liver Disease 2014; 18(1): 59 doi: 10.1016/j.cld.2013.09.002
|
38 |
Shweta Kapil, Ajay Duseja, Bal Krishan Sharma, Bhupesh Singla, Anuradha Chakraborti, Ashim Das, Pallab Ray, Radha K Dhiman, Yogesh Chawla. Genetic polymorphism in <i>CD14</i> gene, a co-receptor of TLR4 associated with non-alcoholic fatty liver disease. World Journal of Gastroenterology 2016; 22(42): 9346-9355 doi: 10.3748/wjg.v22.i42.9346
|
39 |
Ajay Duseja, Reena Das, Ashim Das, R. K. Dhiman, Y. K. Chawla, G. Garewal. Serum Iron Levels and Hepatic Iron Overload in Patients with Nonalcoholic Steatohepatitis. Digestive Diseases and Sciences 2006; 51(10): 1730 doi: 10.1007/s10620-005-9041-9
|